PMC:7195088 / 10354-10758 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"172","span":{"begin":238,"end":246},"obj":"Species"},{"id":"205","span":{"begin":169,"end":180},"obj":"Chemical"},{"id":"244","span":{"begin":96,"end":106},"obj":"Disease"},{"id":"245","span":{"begin":210,"end":218},"obj":"Disease"}],"attributes":[{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Tax:9606"},{"id":"A205","pred":"tao:has_database_id","subj":"205","obj":"MESH:C502936"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"MESH:D007239"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreview"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T53","span":{"begin":96,"end":106},"obj":"Disease"},{"id":"T54","span":{"begin":210,"end":218},"obj":"Disease"}],"attributes":[{"id":"A53","pred":"mondo_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A54","pred":"mondo_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreview"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":139,"end":140},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T34","span":{"begin":156,"end":161},"obj":"http://purl.obolibrary.org/obo/CLO_0007225"},{"id":"T35","span":{"begin":307,"end":308},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T36","span":{"begin":313,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0008416"},{"id":"T37","span":{"begin":313,"end":317},"obj":"http://purl.obolibrary.org/obo/CLO_0050081"}],"text":" worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreview"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T46","span":{"begin":156,"end":161},"obj":"Chemical"},{"id":"T47","span":{"begin":169,"end":180},"obj":"Chemical"}],"attributes":[{"id":"A46","pred":"chebi_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/CHEBI_35209"},{"id":"A47","pred":"chebi_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/CHEBI_64360"}],"text":" worsening while receiving standard supportive care (in the absence of concomitant/superimposed infections). In our opinion, this could be a reasonable off-label use of tocilizumab in these early phases of the COVID-19 pandemic, although patients and physicians should be aware that currently there is only a non–peer-reviewed, noncomparative, observational experience (very low evidence from an unreview"}